Lv2
170 积分 2024-07-24 加入
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia
1个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
2个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
2个月前
已完结
Neuropsychiatric drug development in China: Current status and emerging trends
2个月前
已完结
Chinese innovative drug R&D trends in 2024
2个月前
已完结
Factor XII(a) inhibitors: a review of the patent literature
2个月前
已完结
Factor XI and factor XII as targets for new anticoagulants
2个月前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
2个月前
已完结
FGF-based drug discovery: advances and challenges
2个月前
已完结
Biopharma dealmaking in 2025
3个月前
已完结
皖公网安备34019202002308
